Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

The Cost of Obsessive-compulsive Disorder (OCD) in China (OCD)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT04215549
Recruitment Status : Withdrawn (Because of COVID-19, we cann't carry out recruiting according to the original plan)
First Posted : January 2, 2020
Last Update Posted : November 17, 2020
Sponsor:
Collaborators:
Capital Medical University
Peking University Sixth Hospital
First Affiliated Hospital Xi'an Jiaotong University
Shandong Provincial Hospital
Qingdao Mental Health Center
the First Psychiatric Hospital of Harbin
Qiqihar Medical University
The Second Affiliated Hospital of Xinxiang Medical College
Seventh People's Hospital of Hangzhou
Guangji Hospital Affiliated to Soochow University
The First Affiliated Hospital of Kunming Medical College
Brain Hospital Affiliated to Guangzhou Medical University
Information provided by (Responsible Party):
Zhen Wang, Shanghai Mental Health Center

Brief Summary:
The purpose of this study is to estimate the cost of obsessive-compulsive disorder in China based on the prevalence rate from a social perspective.

Condition or disease Intervention/treatment
Obsessive-Compulsive Disorder Other: No intervention

Detailed Description:
Obsessive-compulsive disorder(OCD) is one of relatively common mental disorders with a prevalence of 1.63% in China. OCD usually begins in adolescence or young adulthood , it will become a chronic disabling disease, if it is not treated in timeand.OCD can be so severe that it can seriously impact on some or all areas of a person's life, bring huge economic burden. At present, there is only one article on the cost of OCD in the United States in the 1990s, and this part of the data in China is blank.A cross-sectional study recruited 600 patients with OCD from 13 hospitals in eastern, western, southern, and northern China. A structured questionnaire was used for face-to-face interviewing to collect costs related to OCD. The direct costs for each patient and indirect costs ffor each patient and their caregivers were calculated . The human capital method is used to calculate indirect costs. Through weighting, the cost of OCD in China is estimated from a social perspective using a bottom-up methodology.

Layout table for study information
Study Type : Observational
Actual Enrollment : 0 participants
Observational Model: Other
Time Perspective: Cross-Sectional
Official Title: The Cost of Obsessive-compulsive Disorder (OCD) in China: Multi-center Cross-sectional Survey Based on Hospital
Actual Study Start Date : January 2, 2020
Estimated Primary Completion Date : October 2020
Estimated Study Completion Date : October 2020


Group/Cohort Intervention/treatment
Participants
OCD patients come from 13 hospitals located in the north, south, east and west of China
Other: No intervention
cross sectional study,no intervention




Primary Outcome Measures :
  1. obsessive-compulsive disorder related costs in China [ Time Frame: 1 year ]
    Estimating the direct and indirect Costs of Chinese OCD based on prevalence from a social perspective


Secondary Outcome Measures :
  1. Direct costs and indirect costs of consumed resources [ Time Frame: 1 year ]
    Direct costs include medical costs and transportation, food, accommodation, etc. corresponding related to clinics.Indirect costs include lost time for patients and family members due to OCD.

  2. other costs directly associated with OCD [ Time Frame: 1 year ]
    Other medical costs and economic loss of disruptive behaviors due to OCD



Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   16 Years to 65 Years   (Child, Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population
patients with obsessive-compulsive disorder are recruited from both outpatient clinics and inpatient departments
Criteria

Inclusion Criteria:

  • primarily diagnosed OCD meet DSM-5 critera
  • 16-65 years old
  • Get informed consent from patients

Exclusion Criteria:

  • Concurrent neuropsychiatric diseases such as schizophrenia, which severely interfere with treatment costs
  • Drug abuser
  • Unable to understand the questionnaire

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT04215549


Locations
Layout table for location information
China, Shanghai
Shanghai Mental Health Center
Shanghai, Shanghai, China, 200030
Sponsors and Collaborators
Shanghai Mental Health Center
Capital Medical University
Peking University Sixth Hospital
First Affiliated Hospital Xi'an Jiaotong University
Shandong Provincial Hospital
Qingdao Mental Health Center
the First Psychiatric Hospital of Harbin
Qiqihar Medical University
The Second Affiliated Hospital of Xinxiang Medical College
Seventh People's Hospital of Hangzhou
Guangji Hospital Affiliated to Soochow University
The First Affiliated Hospital of Kunming Medical College
Brain Hospital Affiliated to Guangzhou Medical University
Investigators
Layout table for investigator information
Principal Investigator: Wang Zhen, PhD,MD Shanghai Mental Health Center
Layout table for additonal information
Responsible Party: Zhen Wang, vice-president, Shanghai Mental Health Center
ClinicalTrials.gov Identifier: NCT04215549    
Other Study ID Numbers: SMHC-OCD-5
First Posted: January 2, 2020    Key Record Dates
Last Update Posted: November 17, 2020
Last Verified: November 2020

Layout table for additional information
Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: No
Additional relevant MeSH terms:
Layout table for MeSH terms
Compulsive Personality Disorder
Obsessive-Compulsive Disorder
Personality Disorders
Mental Disorders
Anxiety Disorders